These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33709978)

  • 21. The Usefulness of Two CXCL13 Assays on Cerebrospinal Fluid for the Diagnosis of Lyme Neuroborreliosis: a Retrospective Study in a Routine Clinical Setting.
    van Gorkom T; van Arkel GHJ; Heron M; Voet W; Thijsen SFT; Kremer K
    J Clin Microbiol; 2021 Aug; 59(9):e0025521. PubMed ID: 34132584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic performance of cerebrospinal fluid free light chains in Lyme neuroborreliosis - a pilot study.
    Tjernberg I; Johansson M; Henningsson AJ
    Clin Chem Lab Med; 2019 Nov; 57(12):2008-2018. PubMed ID: 31199760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.
    Rupprecht TA; Plate A; Adam M; Wick M; Kastenbauer S; Schmidt C; Klein M; Pfister HW; Koedel U
    J Neuroinflammation; 2009 Dec; 6():42. PubMed ID: 20042073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA.
    Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G
    Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCL13 in laboratory diagnosis of Lyme neuroborreliosis-the performance of the recomBead and ReaScan CXCL13 assays in human cerebrospinal fluid samples.
    Haglund S; Lager M; Gyllemark P; Andersson G; Ekelund O; Sundqvist M; Henningsson AJ
    Eur J Clin Microbiol Infect Dis; 2022 Jan; 41(1):175-179. PubMed ID: 34626256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
    Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
    Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point-of-care testing for CXCL13 in Lyme neuroborreliosis.
    Pietikäinen A; Oksi J; Hytönen J
    Diagn Microbiol Infect Dis; 2018 Jul; 91(3):226-228. PubMed ID: 29567125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.
    Skogman BH; Lager M; Henningsson AJ; Tjernberg I
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2221-2229. PubMed ID: 28730535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential for CXCL13 in CSF as a differential diagnostic tool in central nervous system infection.
    Masouris I; Klein M; Ködel U
    Expert Rev Anti Infect Ther; 2020 Sep; 18(9):875-885. PubMed ID: 32479125
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis: An updated systematic review.
    Dersch R; Rauer S
    Eur J Neurol; 2023 Dec; 30(12):3780-3788. PubMed ID: 37565386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokines and chemokines in cerebrospinal fluid in relation to diagnosis, clinical presentation and recovery in children being evaluated for Lyme neuroborreliosis.
    Skogman BH; Lager M; Brudin L; Jenmalm MC; Tjernberg I; Henningsson AJ
    Ticks Tick Borne Dis; 2020 May; 11(3):101390. PubMed ID: 32019724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lyme neuroborreliosis.
    Koedel U; Pfister HW
    Curr Opin Infect Dis; 2017 Feb; 30(1):101-107. PubMed ID: 27820708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A tale of two spirochetes: lyme disease and syphilis.
    Halperin JJ
    Neurol Clin; 2010 Feb; 28(1):277-91. PubMed ID: 19932386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid cytokines in Lyme neuroborreliosis.
    Pietikäinen A; Maksimow M; Kauko T; Hurme S; Salmi M; Hytönen J
    J Neuroinflammation; 2016 Oct; 13(1):273. PubMed ID: 27756335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lyme neuroborreliosis in children.
    Tuerlinckx D; Glupczynski Y
    Expert Rev Anti Infect Ther; 2010 Apr; 8(4):455-63. PubMed ID: 20377339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. False positive Lyme serology due to syphilis: report of 6 cases and review of the literature.
    Naesens R; Vermeiren S; Van Schaeren J; Jeurissen A
    Acta Clin Belg; 2011; 66(1):58-9. PubMed ID: 21485767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
    Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
    J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
    Ljøstad U; Mygland Å
    J Neurol; 2008 May; 255(5):782. PubMed ID: 27517589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lyme neuroborreliosis-epidemiology, diagnosis and management.
    Koedel U; Fingerle V; Pfister HW
    Nat Rev Neurol; 2015 Aug; 11(8):446-56. PubMed ID: 26215621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis--the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic.
    Djukic M; Schmidt-Samoa C; Nau R; von Steinbüchel N; Eiffert H; Schmidt H
    Eur J Neurol; 2011 Apr; 18(4):547-55. PubMed ID: 20977545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.